Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15610 | 28811690 | Indian J Clin Biochem | Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation. | 2016 | Details |
| A15611 | 28811651 | Int J Obes (Lond) | iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. | 2017 | Details |
| A15617 | 28805745 | Children (Basel) | Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics. | 2017 | Details |
| A15618 | 28805669 | Nutrients | Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. | 2017 | Details |
| A15620 | 28804947 | J Clin Periodontol | Periodontitis and Non-alcoholic Fatty Liver Disease, a population-based cohort investigation in the Study of Health in Pomerania. | 2017 | Details |
| A15628 | 28802074 | Hepatology | Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. | 2017 | Details |
| A15633 | 28797988 | Turk J Gastroenterol | Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. | 2017 | Details |
| A15635 | 28797077 | PLoS One | Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1. | 2017 | Details |
| A15636 | 28796993 | Digestion | Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model. | 2017 | Details |
| A15643 | 28791501 | J Gastroenterol | Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. | 2017 | Details |
| A15656 | 28777914 | Can J Physiol Pharmacol | Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption. | 2017 | Details |
| A15658 | 28777879 | Hepatology | Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. | 2017 | Details |
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15685 | 28760353 | Clin Res Hepatol Gastroenterol | Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. | 2017 | Details |
| A15690 | 28759573 | PLoS One | Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis. | 2017 | Details |
| A15694 | 28758096 | Ann Transl Med | Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. | 2017 | Details |
| A15698 | 28753963 | Nutrients | The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats. | 2017 | Details |
| A15701 | 28752050 | Mol Metab | Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. | 2017 | Details |
| A15705 | 28751149 | Diabetes Metab Syndr | The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2017 | Details |
| A15714 | 28748119 | J Adv Res | Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. | 2016 | Details |
| A15723 | 30603331 | Diabetol Int | Immune regulation of glucose and lipid metabolism. | 2017 | Details |
| A15728 | 28741239 | Obes Surg | Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features. | 2018 | Details |
| A15735 | 28737569 | J Pediatr Gastroenterol Nutr | Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15746 | 28730823 | Physiol Res | Pathophysiological analysis of the progression of hepatic lesions in STAM mice. | 2017 | Details |
| A15767 | 28720429 | Pharmacol Ther | Stable isotope-based flux studies in nonalcoholic fatty liver disease. | 2017 | Details |
| A15770 | 28718838 | Nutrients | Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats. | 2017 | Details |
| A15772 | 28718215 | Hepatology | USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity. | 2017 | Details |
| A15776 | 28714900 | Int J Mol Sci | A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15777 | 28714405 | Curr Pharm Des | Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter. | 2017 | Details |
| A15781 | 28711683 | Biochimie | Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice. | 2017 | Details |
| A15784 | 28710554 | Obes Surg | Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A15794 | 28706613 | Avicenna J Med Biotechnol | Major Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients. | 2020 | Details |
| A15798 | 28705172 | BMC Endocr Disord | Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss. | 2017 | Details |
| A15807 | 28699612 | Indian Pediatr | Relationship Between Immune Parameters and Non-alcoholic Fatty Liver Disease in Obese Children. | 2017 | Details |
| A15808 | 28699503 | Curr Med Chem | Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. | 2017 | Details |
| A15811 | 28698350 | BMJ Open | Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. | 2017 | Details |
| A15812 | 28696785 | Arch Physiol Biochem | Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model. | 2017 | Details |
| A15820 | 28694246 | Eur J Endocrinol | MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2017 | Details |
| A15834 | 28689596 | Clin Liver Dis | Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation. | 2017 | Details |
| A15836 | 28689378 | Postepy Biochem | The roles of annexins in vascular endothelium dysfunction accompanying diabetes mellitus type 2. | 2017 | Details |
| A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
| A15849 | 28683283 | Cell Metab | Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. | 2017 | Details |
| A15850 | 28681988 | Diabetes Obes Metab | Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial. | 2017 | Details |
| A15852 | 28680417 | Front Endocrinol (Lausanne) | Alternative RNA Splicing in the Pathogenesis of Liver Disease. | 2017 | Details |
| A15856 | 28679028 | Liver Int | Hepatic iron is the major determinant of serum ferritin in NAFLD patients. | 2017 | Details |
| A15872 | 28676026 | Curr Vasc Pharmacol | A Critical Approach of Guideline Therapeutic Recommendations for NAFLD. | 2018 | Details |
| A15877 | 28676018 | Curr Vasc Pharmacol | Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? | 2018 | Details |
| A15882 | 28673684 | Toxicol Appl Pharmacol | The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. | 2017 | Details |
| A15886 | 28670854 | J Gastroenterol Hepatol | Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ. | 2018 | Details |
| A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
| A15894 | 28666456 | Lipids Health Dis | Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. | 2017 | Details |
| A15901 | 28660493 | Diabetologia | Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study. | 2017 | Details |
| A15903 | 28660148 | J Clin Transl Hepatol | Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15909 | 28655985 | Ann Gastroenterol | Circulating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markers. | 2017 | Details |
| A15917 | 28652891 | World J Hepatol | Non-alcoholic fatty liver disease: An expanded review. | 2017 | Details |
| A15919 | 28652657 | World J Gastroenterol | Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study. | 2017 | Details |
| A15920 | 28652650 | World J Gastroenterol | Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. | 2017 | Details |
| A15929 | 28647324 | Trends Endocrinol Metab | AMPK as a Therapeutic Target for Treating Metabolic Diseases. | 2017 | Details |
| A15930 | 28647291 | Clin Nutr | Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial. | 2017 | Details |
| A15940 | 28642059 | J Hepatol | New trends on obesity and NAFLD in Asia. | 2017 | Details |
| A15942 | 28641788 | Metabolism | Non-alcoholic fatty liver disease: A sign of systemic disease. | 2017 | Details |
| A15943 | 28641784 | Metabolism | Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. | 2017 | Details |
| A15949 | 28640216 | Nutrients | A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15955 | 28637594 | Metabolism | Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population. | 2017 | Details |
| A15956 | 28637520 | Br J Nutr | Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver. | 2017 | Details |
| A15959 | 28637104 | Korean J Gastroenterol | [Treatment Options in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15961 | 28637102 | Korean J Gastroenterol | [The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15962 | 28637101 | Korean J Gastroenterol | [Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15975 | 28630692 | J Nutr Sci | Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. | 2017 | Details |
| A15976 | 28630632 | Evid Based Complement Alternat Med | Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro. | 2017 | Details |
| A15980 | 28628263 | Hepatol Res | Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15996 | 28621339 | Nat Rev Endocrinol | Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. | 2017 | Details |
| A15999 | 28620012 | Clin Sci (Lond) | Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. | 2017 | Details |
| A16002 | 28618991 | Curr Med Chem | Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | 2018 | Details |
| A16010 | 28612550 | Sichuan Da Xue Xue Bao Yi Xue Ban | [Serum Wnt5a and Its Associations with Liver Steatosis and Fibrosis in Overweight and Obese People]. | 2017 | Details |
| A16012 | 28612285 | J Endocrinol Invest | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | 2017 | Details |
| A16015 | 28611297 | Oncotarget | Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis. | 2017 | Details |
| A16016 | 28611274 | Ann Hepatol | Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis. | 2018 | Details |
| A16017 | 28609252 | Gut Microbes | Fecal microbiota transplantation in metabolic syndrome: History, present and future. | 2017 | Details |
| A16020 | 28607535 | Mediators Inflamm | Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study. | 2017 | Details |
| A16021 | 28606575 | Nutrition | Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. | 2017 | Details |
| A16032 | 28600116 | Surg Obes Relat Dis | Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. | 2017 | Details |
| A16033 | 28599248 | Biomed Pharmacother | The multifaceted role of natriuretic peptides in metabolic syndrome. | 2017 | Details |
| A16034 | 28598982 | PLoS One | α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. | 2017 | Details |
| A16040 | 28596784 | Front Genet | INDY-A New Link to Metabolic Regulation in Animals and Humans. | 2017 | Details |
| A16041 | 28596677 | World J Gastroenterol | Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. | 2017 | Details |
| A16042 | 28596431 | Eur Respir J | Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. | 2017 | Details |
| A16045 | 28595552 | Curr Med Chem | Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications. | 2018 | Details |
| A16050 | 28593786 | Rev Esp Enferm Dig | Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. | 2017 | Details |
| A16051 | 28593739 | Hepatol Res | Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease. | 2017 | Details |
| A16054 | 28592311 | Trials | The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. | 2017 | Details |
| A16056 | 28591572 | Cell Rep | Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. | 2017 | Details |
| A16061 | 28587303 | Children (Basel) | The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16073 | 28585211 | Adv Exp Med Biol | Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16074 | 28585204 | Adv Exp Med Biol | Insulin Resistance, Obesity and Lipotoxicity. | 2017 | Details |
| A16077 | 28581332 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. | 2017 | Details |
| A16079 | 28580850 | Orv Hetil | [Advances in the pathogenesis of non alcoholic fatty liver disease]. | 2017 | Details |
| A16083 | 28578672 | Lipids Health Dis | Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. | 2017 | Details |
| A16092 | 28575232 | J Clin Endocrinol Metab | Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. | 2017 | Details |
| A16096 | 28573067 | World J Gastrointest Pathophysiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2017 | Details |